These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14842972)

  • 1. [Use of glucantime in infantile kala-azar].
    TONDI IV; RIPA F
    Minerva Pediatr; 1951 Mar; 3(3):184-6. PubMed ID: 14842972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of kala-azar by glucantime].
    DURAND P; BENMUSSA ; CARUANA
    Cah Med Union Fr; 1950 Oct; 5(43):655-9. PubMed ID: 14792320
    [No Abstract]   [Full Text] [Related]  

  • 3. [Two cases of kala-azar treated with glucantime].
    MATOS J; VELASCO JA
    Acta Pediatr Esp; 1955 Nov; 13(155):959-63. PubMed ID: 13301754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Polyneuritic complications after treatment of kala-azar in the adult with 2168 R.P].
    PORTIER A; BOULARD C; MASSONNAT J
    Alger Medicale; 1951 Feb; 55(2):674-7. PubMed ID: 14829391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Agranulocytosis caused by glucantime in the treatment of kala-azar].
    Gutiérrez Rodero F
    Med Clin (Barc); 1986 Mar; 86(10):437. PubMed ID: 3713304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
    Gutiérrez Rodero F; Moya Jeromini I; Ortiz de la Tabla Ducasse V; Pozuelo González A
    Med Clin (Barc); 1985 May; 84(20):840. PubMed ID: 4033266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Visceral leishmaniasis (kala-azar): 1st case observed in Chile].
    Osorio G; Moyano C; Caravagno C; Miranda C; Ubilla M; Maturana G; Retamales I
    Rev Med Chil; 1984 Mar; 112(3):261-6. PubMed ID: 6473968
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of kala-azar].
    Neves J
    Rev Paul Med; 1983; 101(6):237-9. PubMed ID: 6677985
    [No Abstract]   [Full Text] [Related]  

  • 10. Kala-azar in Afghanistan.
    Singh M; Arya LS; Aram GN; Fazal MI; Qureshi MA; Goel RG
    J Trop Med Hyg; 1982 Oct; 85(5):201-4. PubMed ID: 7176002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
    de la Cruz Amorós E; Lambruschini Ferri N; Rodríguez Miguélez JM; Torres Simón JM
    An Esp Pediatr; 1988 Jul; 29(1):77-9. PubMed ID: 3190011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kala-azar in pregnant women].
    Massip P; Goutner C; Dupic Y; Navarrot P
    Presse Med; 1986 May; 15(20):933. PubMed ID: 2940581
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kala-azar. Apropos of a case report in a Belgian woman].
    Coutellier P; Delgrange B
    Acta Clin Belg; 1989; 44(5):362-3. PubMed ID: 2609847
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
    De Pablos Gallego JM; Cabrera Torres A; Almagro M; De Puerta S; López Garrido P; Gómez Morales M; Esquivias JJ
    Rev Clin Esp; 1982 Mar; 164(6):417-20. PubMed ID: 7111811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar].
    Ben Said M; Ben Rachid MS
    Ann Soc Belg Med Trop; 1985; 65(1):31-40. PubMed ID: 3890778
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
    Alborzi A; Pouladfar G; Attar A; Falahi F; Jafarpour Z; Karimi A; Kadivar MR
    Am J Trop Med Hyg; 2017 Jan; 96(1):182-189. PubMed ID: 27879460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.